OPRX (OptimizeRx) Tariff Resilience Score: 7/10 (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OPRX OptimizeRx Corp OPRX
59 GF Score
Price $6.70
GF Value $12.89
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is OptimizeRx Tariff Resilience Score?

OptimizeRx OPRX +0.45% 59 Tariff Resilience Score is 7 as of Jul. 19, 2026. GuruFocus rates OPRX with a GF Score™ of 59/100 and a GF Value™ of $12.89 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 669 Healthcare Providers & Services companies, OptimizeRx ranks better than 89.39% on this metric.

OptimizeRx has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

OptimizeRx has Healthcare technology company with minimal direct exposure to tariffs. However, any tariffs affecting the healthcare industry could indirectly impact operations and partnerships.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes OptimizeRx might have Highly Resilient.

OptimizeRx  (NAS:OPRX) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

OptimizeRx Tariff Resilience Score Related Terms

OPRX vs CCLD, DH, HCAT: Tariff Resilience Score Comparison

For the Health Information Services subindustry, OptimizeRx's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OptimizeRx Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, OptimizeRx's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where OptimizeRx's Tariff Resilience Score falls into.


OPRX
59GF Score
OptimizeRx Corp OPRX
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
OptimizeRx (OPRX) has a Tariff Resilience Score of 7 as of Jul. 19, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, OptimizeRx ranks #71 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 10.6%.
Is OptimizeRx's Tariff Resilience Score too high?
OptimizeRx's current Tariff Resilience Score is 7. Based on the distribution chart, OptimizeRx ranks #71 out of 669 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, OptimizeRx has a GF Score™ of 59/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does OptimizeRx's Tariff Resilience Score compare to CCLD and DH?
According to the Healthcare Providers & Services industry distribution chart, OptimizeRx ranks #71 out of 669 companies for Tariff Resilience Score. This places OptimizeRx in the top 11% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. OptimizeRx's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OptimizeRx stock overvalued right now?
Based on GuruFocus' analysis, OptimizeRx (OPRX) is currently considered Significantly Undervalued. The stock's GF Value™ is $12.89, compared to a current price of $6.70 — trading 48.1% below its estimated fair value. The current Tariff Resilience Score is 7. OptimizeRx's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For OptimizeRx (OPRX), the current Tariff Resilience Score is 7 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OptimizeRx (OPRX) Overvalued in 2026?

Based on GuruFocus' analysis, OptimizeRx stock appears to be undervalued. The current stock price of $6.70 is trading 48.1% below its estimated GF Value™ of $12.89. GuruFocus considers OptimizeRx to be Significantly Undervalued.

Key valuation signals for OPRX:

  • Tariff Resilience Score: 7
  • GF Value™: $12.89 vs. price of $6.70 (48.1% below fair value)
  • GF Score™: 59/100 with 3 warning signs

No single metric tells the full story. See the OPRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OptimizeRx Business Description

Address 260 Charles Street, Suite 302, Waltham, MA, USA, 02453
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
59GF Score

Get the complete analysis for OPRX

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.70
Price
$12.89
GF Value